Shuttle Pharmaceuticals Holdings (SHPH) Total Liabilities (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Total Liabilities of $8.5 million for Q1 2026, up 317.95% year-over-year from $2.0 million in Q1 2025, and up 2.94% quarter-over-quarter from $8.2 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Total Liabilities (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Total Liabilities history runs 6 years deep, the most recent figure standing at $8.5 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 317.95% year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $8.5 million (up 317.95% YoY), while the FY2025 annual figure was $8.2 million, up 357.48% from the prior year.
- Total Liabilities for Q1 2026 stood at $8.5 million, up from $8.2 million in the prior quarter.
- The five-year high for Total Liabilities was $8.5 million in Q1 2026, with the low at $975676.0 in Q4 2022.
- The 5-year median for Total Liabilities is $2.0 million (2024), against an average of $2.8 million.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities plunged 57.2% in 2022, then soared 357.48% in 2025.
- Shuttle Pharmaceuticals Holdings' Total Liabilities stood at $975676.0 in 2022, then soared by 94.32% to $1.9 million in 2023, then retreated by 5.21% to $1.8 million in 2024, then jumped by 357.48% to $8.2 million in 2025, then increased by 2.94% to $8.5 million in 2026.
- Business Quant data shows SHPH's Total Liabilities at $8.5 million in Q1 2026, $8.2 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.91 Mn | 1.91 Mn | - | 8.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.46 Mn |
| Dec 31, 2025 | 8.22 Mn |
| Sep 30, 2025 | 2.15 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 2.02 Mn |
| Dec 31, 2024 | 1.80 Mn |
| Sep 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 1.99 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 1.77 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 3.53 Mn |
| Dec 31, 2022 | 975,676.00 |
| Sep 30, 2022 | 977,141.00 |
| Dec 31, 2021 | 2.28 Mn |